Affordable Access

Publisher Website

Poor clinical course in a child with myelodysplastic syndrome and del(13)(q14q22)

Authors
Journal
Cancer Genetics and Cytogenetics
0165-4608
Publisher
Elsevier
Publication Date
Volume
163
Issue
1
Identifiers
DOI: 10.1016/j.cancergencyto.2005.04.008
Disciplines
  • Medicine

Abstract

Abstract Myelodysplastic syndromes (MDS) are rare in children, representing 3% or less of all hematopoietic malignancies. Cytogenetic abnormalities, such as −7/7q-, +8, and +21 have been reported in 55–80% of children with MDS. Cytogenetic studies have an important impact on diagnosis, treatment selection, and monitoring therapeutic protocols when combined with morphologic data. We report on a pediatric case of MDS with the presence of the rare clonal abnormality del(13)(q14q22) which underwent a malignant transformation to leukemia and ran a very poor clinical course.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Poor clinical course in a child with myelodysplast...

on Cancer Genetics and Cytogeneti... November 2005

Deletion 22q13.3 syndrome

on Orphanet Journal of Rare Disea... Jan 01, 2008

22q13 deletion syndrome.

on American Journal of Medical Ge... Jun 15, 2001

Clinical utility gene card for: deletion 22q13 syn...

on European Journal of Human Gene... April 2011
More articles like this..